Litigation Details for Assertio Therapeutics, Inc. v. Patrin Pharma, Inc. (N.D. Ill. 2020)
✉ Email this page to a colleague
Assertio Therapeutics, Inc. v. Patrin Pharma, Inc. (N.D. Ill. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-08-27 |
| Court | District Court, N.D. Illinois | Date Terminated | 2021-03-15 |
| Cause | 35:183 Patent Infringement | Assigned To | Charles Petros Kocoras |
| Jury Demand | None | Referred To | |
| Parties | PATRIN PHARMA, INC. | ||
| Patents | 7,759,394; 8,097,651; 8,927,604; 9,827,197 | ||
| Attorneys | Patrick Conlin Gallagher | ||
| Firms | Duane Morris LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Assertio Therapeutics, Inc. v. Patrin Pharma, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Assertio Therapeutics, Inc. v. Patrin Pharma, Inc. (N.D. Ill. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-08-27 | 1 | involving U.S. Patent No. 7,759,394 (“the ’394 patent”), U.S, Patent No. 8,097,651, (“the ’651 patent”), U.S.…U.S. Patent No. 8,927,604 (“the ’604 patent”) and U.S Patent No. 9,827,197 (“the ’197 patent”) (collectively…355(b)(1), the ’394 patent, the ’651 patent, the ’604 patent and the ’197 patent are listed in the FDA… 21. The ’394 patent, the ’651 patent, the ’604 patent and the ’197 patent cover Cambia®. …certification”) that the ’394 patent, the ’651 patent, the ’604 patent and the ’197 patent are invalid, unenforceable | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
